| Matthias M Nurnberger, MD | |
|
463 Worcester Rd, Suite 206, Framingham, MA 01701-5356 | |
| (508) 598-9300 | |
| (508) 598-9290 |
| Full Name | Matthias M Nurnberger |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 463 Worcester Rd, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982651774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 154538 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caretenders | Needham heights, MA | Home health agency |
| Metrowest Medical Center | Framingham, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charles River Medical Associates, Pc | 3476630450 | 98 |
News Archive
Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Engineers have developed a type of "electronic skin" that monitors a person's health without malfunctioning or peeling away, even when a wearer is perspiring.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its newborn screening laboratory service, PerkinElmer Genetics, has launched a new panel to screen for six Lysosomal Storage Disorders (LSDs) as an addition to its current newborn testing and diagnostics portfolio.
KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm's proprietary Ligand Activated Therapy (LAT) prodrug approach.
› Verified 2 days ago
| Entity Name | Charles River Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598215204 PECOS PAC ID: 3476630450 Enrollment ID: O20161122000110 |
News Archive
Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Engineers have developed a type of "electronic skin" that monitors a person's health without malfunctioning or peeling away, even when a wearer is perspiring.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its newborn screening laboratory service, PerkinElmer Genetics, has launched a new panel to screen for six Lysosomal Storage Disorders (LSDs) as an addition to its current newborn testing and diagnostics portfolio.
KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm's proprietary Ligand Activated Therapy (LAT) prodrug approach.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthias M Nurnberger, MD 171 Main St Ste 203b, Ashland, MA 01721-1187 Ph: (508) 881-3029 | Matthias M Nurnberger, MD 463 Worcester Rd, Suite 206, Framingham, MA 01701-5356 Ph: (508) 598-9300 |
News Archive
Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Engineers have developed a type of "electronic skin" that monitors a person's health without malfunctioning or peeling away, even when a wearer is perspiring.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its newborn screening laboratory service, PerkinElmer Genetics, has launched a new panel to screen for six Lysosomal Storage Disorders (LSDs) as an addition to its current newborn testing and diagnostics portfolio.
KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm's proprietary Ligand Activated Therapy (LAT) prodrug approach.
› Verified 2 days ago
Dr. Wendy Elizabeth Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Cochituate Rd, Framingham, MA 01701 Phone: 508-628-9660 Fax: 508-628-9668 | |
Dr. Sira Korpaisarn, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 | |
Dagem Getahun, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1555 | |
Dr. Pedro Arthur Macedo De Freitas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Yung-chen Wu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1572 | |
Richard Stephen Blumenfeld, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-879-7904 Fax: 508-872-8594 | |
Rejane Guerrier, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 959 Concord St Ste 200, Framingham, MA 01701 Phone: 508-532-0223 Fax: 508-875-0049 |